3 research outputs found

    Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial

    Get PDF
    Background: Safety and immunogenicity of COVID-19 vaccines when co-administered with influenza vaccines have not yet been reported. Methods: A sub-study on influenza vaccine co-administration was conducted as part of the phase 3 randomised trial of NVX-CoV2373’s safety and efficacy; ~400 participants meeting main study entry criteria, with no contraindications to influenza vaccination, were enroled. After randomisation to receive NVX-CoV2373 or placebo, sub-study participants received an open-label influenza vaccine at the same time as the first dose of NVX-CoV2373. Reactogenicity was evaluated for 7 days post-vaccination plus monitoring for unsolicited adverse events (AEs), medically-attended AEs (MAAEs), and serious AEs (SAEs). Vaccine efficacy against COVID-19 was assessed. Findings: Sub-study participants were younger (median age 39; 6.7 % ≥65 years), more racially diverse, and had fewer comorbid conditions than main study participants. Reactogenicity events more common in co-administration group included tenderness (70.1% vs 57.6%) or pain (39.7% vs 29.3%) at injection site, fatigue (27.7% vs 19.4%), and muscle pain (28.3% vs 21.4%). Rates of unsolicited AEs, MAAEs, and SAEs were low and balanced between the two groups. Co-administration resulted in no change to influenza vaccine immune response, while a reduction in antibody responses to the NVX-CoV2373 vaccine was noted. Vaccine efficacy against COVID-19 was 87.5% (95% CI: -0.2, 98.4) in those 18-<65 years in the sub-study while efficacy in the main study was 89.8% (95% CI: 79.7, 95.5).  Interpretation: This is the first study to demonstrate safety, immunogenicity, and efficacy of a COVID-19 vaccine when co-administered with influenza vaccines

    Re:Voice

    No full text
    Re:Voice, a participatory theatre performance co-created with Tuesday Fun Night Club Choir from Penzance, forms part of a major European research project Re-voicing Cultural Landscapes led by Falmouth University in collaboration with Universities of Latvia, Tartu (Estonia) and Groningen (The Netherlands), exploring cultural traditions in Cornwall and other regions in Europe which asked how living heritage can be made vital and resilient. The project has been made possible by support from Arts Council England, Feast Cornwall and Falmouth University, and it is funded by the Arts and Humanities Research Council. Directed by Agnieszka Blonska with imPOSSIBLE producing, choir leader Victoria Abbott and the Tuesday Night Fun Club; with lighting and projection by Joshua Pharo and choreography by Jennifer Fletcher and Claud Tonietto. The show premiered during the Last Weekend at Tate St Ives on April 29th, 2023
    corecore